Literature DB >> 12725354

The epidemiology of vancomycin-resistant Enterococcus colonization in a medical intensive care unit.

David K Warren1, Marin H Kollef, Sondra M Seiler, Scott K Fridkin, Victoria J Fraser.   

Abstract

OBJECTIVE: To determine the epidemiology of colonization with vancomycin-resistant Enterococcus (VRE) among intensive care unit (ICU) patients.
DESIGN: Ten-month prospective cohort study.
SETTING: A 19-bed medical ICU of a 1,440-bed teaching hospital.
METHODS: Patients admitted to the ICU had rectal swab cultures for VRE on admission and weekly thereafter. VRE-positive patients were cared for using contact precautions. Clinical data, including microbiology reports, were collected prospectively during the ICU stay.
RESULTS: Of 519 patients who had admission stool cultures, 127 (25%) had cultures that were positive for VRE. Risk factors for VRE colonization identified by multiple logistic regression analysis were hospital stay greater than 3 days prior to ICU admission (adjusted odds ratio [AOR], 3.6; 95% confidence interval [CI95], 2.3 to 5.7), chronic dialysis (AOR, 2.4; CI95, 1.2 to 4.5), and having been admitted to the study hospital one to two times (AOR, 2.3; CI95, 1.4 to 3.8) or more than two times (AOR, 6.5; CI95, 3.7 to 11.6) within the past 12 months. Of the 352 VRE-negative patients who had one or more follow-up cultures, 74 (21%) became VRE positive during their ICU stay (27 cases per 1,000 patient-ICU days).
CONCLUSION: The prevalence of VRE culture positivity on ICU admission was high and a sizable fraction of ICU patients became VRE positive during their ICU stay despite contact precautions for VRE-positive patients. This was likely due in large part to prior VRE exposures in the rest of the hospital where these control measures were not being used.

Entities:  

Mesh:

Year:  2003        PMID: 12725354     DOI: 10.1086/502199

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  10 in total

1.  Endocarditis caused by resistant enterococcus: an overview.

Authors:  Katherine Reyes; Marcus Zervos
Journal:  Curr Infect Dis Rep       Date:  2013-08       Impact factor: 3.725

2.  Methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococci in rural communities, western United States.

Authors:  Kurt B Stevenson; Katy Searle; Gregory J Stoddard; Matthew Samore
Journal:  Emerg Infect Dis       Date:  2005-06       Impact factor: 6.883

3.  Risk factors associated with vancomycin-resistant enterococcus in intensive care unit settings in saudi arabia.

Authors:  Mahmoud Shorman; Jaffar A Al-Tawfiq
Journal:  Interdiscip Perspect Infect Dis       Date:  2013-08-20

4.  Evaluation of vancomycin therapy in the adult ICUs of a teaching hospital in southern Iran.

Authors:  Afsaneh Vazin; Motahare Mahi Birjand; Masoud Darake
Journal:  Drug Healthc Patient Saf       Date:  2018-04-05

5.  Reaction of bis[(2-chlorocarbonyl)phenyl] Diselenide with Phenols, Aminophenols, and Other Amines towards Diphenyl Diselenides with Antimicrobial and Antiviral Properties.

Authors:  Mirosław Giurg; Anna Gołąb; Jakub Suchodolski; Rafał Kaleta; Anna Krasowska; Egbert Piasecki; Magdalena Piętka-Ottlik
Journal:  Molecules       Date:  2017-06-12       Impact factor: 4.411

6.  Impact of a vancomycin-resistant Enterococcus (VRE) screening result on appropriateness of antibiotic therapy.

Authors:  Jenna L Reynolds; Raelene E Trudeau; Maria Teresa Seville; Lynn Chan
Journal:  Antimicrob Steward Healthc Epidemiol       Date:  2021-11-03

7.  Vancomycin-resistant Enterococcus faecium COLONIZATION and Clostridium difficile infection in a HEMATOLOGIC patient.

Authors:  Ivana Goić-Barišić; Marina Radić; Anita Novak; Žana Rubić; Nataša Boban; Boris Lukšić; Marija Tonkić
Journal:  Acta Clin Croat       Date:  2020-09       Impact factor: 0.780

8.  Trends and significance of VRE colonization in the ICU: a meta-analysis of published studies.

Authors:  Panayiotis D Ziakas; Rachana Thapa; Louis B Rice; Eleftherios Mylonakis
Journal:  PLoS One       Date:  2013-09-27       Impact factor: 3.240

9.  Incidence of and risk factors for infection or colonization of vancomycin-resistant enterococci in patients in the intensive care unit.

Authors:  Sung-Ching Pan; Jann-Tay Wang; Yee-Chun Chen; Yin-Yin Chang; Mei-Ling Chen; Shan-Chwen Chang
Journal:  PLoS One       Date:  2012-10-10       Impact factor: 3.240

10.  Healthcare-associated vancomycin resistant Enterococcus faecium infections in the Mansoura University Hospitals intensive care units, Egypt.

Authors:  Dalia Moemen; Doaa Tawfeek; Wafaa Badawy
Journal:  Braz J Microbiol       Date:  2015-07-01       Impact factor: 2.476

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.